Anika Therapeutics (ANIK) Hit By BidaskScore Downgrade; 2 Analysts Bullish Oasis Petroleum Inc. (OAS)

Anika Therapeutics, Inc. (NASDAQ:ANIK) Logo

Anika Therapeutics Inc (NASDAQ:ANIK) was cut by BidaskScore to a Sell rating in a an analyst report issued to clients and investors on Wednesday, 25 September.

Among 7 analysts covering Oasis Petroleum (NYSE:OAS), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Oasis Petroleum has $14 highest and $3.5000 lowest target. $6.43’s average target is 79.11% above currents $3.59 stock price. Oasis Petroleum had 11 analyst reports since March 28, 2019 according to SRatingsIntel. The firm earned “Market Perform” rating on Tuesday, April 23 by IFS Securities. On Thursday, August 8 the stock rating was downgraded by Raymond James to “Outperform”. Morgan Stanley downgraded Oasis Petroleum Inc. (NYSE:OAS) on Monday, June 24 to “Equal-Weight” rating. On Wednesday, June 19 the stock rating was maintained by Stifel Nicolaus with “Buy”. On Monday, August 26 the stock rating was downgraded by Ladenburg Thalmann to “Neutral”. Wells Fargo maintained Oasis Petroleum Inc. (NYSE:OAS) rating on Friday, September 20. Wells Fargo has “Market Perform” rating and $600 target. Morgan Stanley maintained the stock with “Equal-Weight” rating in Friday, July 12 report. See Oasis Petroleum Inc. (NYSE:OAS) latest ratings:

20/09/2019 Broker: Wells Fargo Rating: Market Perform Old Target: $7.0000 New Target: $6.0000 Maintain
30/08/2019 Broker: Barclays Capital Rating: Equal-Weight New Target: $3.5000 Initiates Coverage On
26/08/2019 Broker: Ladenburg Thalmann Old Rating: Buy New Rating: Neutral Old Target: $7.0000 New Target: $5.0000 Downgrade
23/08/2019 Broker: M Partners Rating: Buy Initiates Coverage On
08/08/2019 Broker: Raymond James Old Rating: Strong Buy New Rating: Outperform Old Target: $7.5000 New Target: $4.0000 Downgrade
07/08/2019 Broker: Williams Capital Group Old Rating: Buy New Rating: Hold Downgrade
12/07/2019 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $6.0000 New Target: $5.5000 Maintain
24/06/2019 Broker: Morgan Stanley Old Rating: Overweight New Rating: Equal-Weight Old Target: $7.0000 New Target: $6.0000 Downgrade
19/06/2019 Broker: Stifel Nicolaus Rating: Buy New Target: $14 Maintain
23/04/2019 Broker: IFS Securities Old Rating: Outperform New Rating: Market Perform Old Target: $8.0000 New Target: $7.0000 Downgrade

More notable recent Anika Therapeutics, Inc. (NASDAQ:ANIK) news were published by: which released: “Key events next week - healthcare - Seeking Alpha” on September 13, 2019, also with their article: “Top Analyst Upgrades and Downgrades: Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Disney, Edwards Lifesciences, Occidental and More - 24/7 Wall St.” published on September 23, 2019, published: “Stocks To Watch: Waiting On The Fed - Seeking Alpha” on September 14, 2019. More interesting news about Anika Therapeutics, Inc. (NASDAQ:ANIK) were released by: and their article: “Anika Therapeutics to Host Analyst and Investor Day on September 18, 2019 - Business Wire” published on September 04, 2019 as well as‘s news article titled: “Anika to Participate in the 2019 Morgan Stanley Global Healthcare Conference on September 10, 2019 - Business Wire” with publication date: September 03, 2019.

Investors sentiment decreased to 1.4 in Q2 2019. Its down 0.37, from 1.77 in 2019Q1. It turned negative, as 16 investors sold Anika Therapeutics, Inc. shares while 42 reduced holdings. 35 funds opened positions while 46 raised stakes. 13.49 million shares or 3.81% more from 13.00 million shares in 2019Q1 were reported. Susquehanna Int Gp Ltd Liability Partnership, Pennsylvania-based fund reported 6,810 shares. Voloridge Invest Mngmt Ltd Liability Corporation holds 0.01% of its portfolio in Anika Therapeutics, Inc. (NASDAQ:ANIK) for 6,610 shares. Moreover, Parallax Volatility Advisers Limited Partnership has 0% invested in Anika Therapeutics, Inc. (NASDAQ:ANIK) for 36,251 shares. Thompson Siegel And Walmsley Ltd Llc, Virginia-based fund reported 48,602 shares. California State Teachers Retirement Systems holds 0% or 21,256 shares. Oaktop Capital Mngmt Ii L P reported 12,500 shares. Savings Bank Of Montreal Can stated it has 0% in Anika Therapeutics, Inc. (NASDAQ:ANIK). Price T Rowe Inc Md stated it has 10,553 shares. First Republic Investment Mngmt owns 40,849 shares or 0.01% of their US portfolio. Credit Suisse Ag holds 0% of its portfolio in Anika Therapeutics, Inc. (NASDAQ:ANIK) for 9,029 shares. Magnetar Fincl Ltd Liability Company stated it has 0.01% of its portfolio in Anika Therapeutics, Inc. (NASDAQ:ANIK). Stifel Fincl owns 98,620 shares. 39,879 are held by Deutsche Bank Ag. Dimensional Fund Lp accumulated 0.02% or 1.05 million shares. 1,107 were reported by Grp Inc One Trading Limited Partnership.

Analysts await Anika Therapeutics, Inc. (NASDAQ:ANIK) to report earnings on October, 23. They expect $0.41 earnings per share, down 22.64% or $0.12 from last year’s $0.53 per share. ANIK’s profit will be $5.65 million for 32.16 P/E if the $0.41 EPS becomes a reality. After $0.67 actual earnings per share reported by Anika Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -38.81% negative EPS growth.

The stock decreased 0.32% or $0.17 during the last trading session, reaching $52.75. About 154,015 shares traded. Anika Therapeutics, Inc. (NASDAQ:ANIK) has risen 39.72% since September 25, 2018 and is uptrending. It has outperformed by 39.72% the S&P500. Some Historical ANIK News: 18/04/2018 - Anika to Issue First-Quarter 2018 Financial Results and Business Highlights on Wednesday, May 2; 23/05/2018 - ANIKA THERAPEUTICS REPORTS $30M ACCELERATED SHARE BUYBACK; 02/05/2018 - Anika Therapeutics Now Expects Total Rev Growth to Be Flat for the Full Yr of 2018; 07/05/2018 - Anika at Deutsche Bank Health Care Conference Tomorrow; 23/05/2018 - Anika Therapeutics Announces $30 Million Accelerated Share Repurchase; 05/03/2018 - ANIKA THERAPEUTICS NAMES DARLING CEO; SHERWOOD TO RETIRE; 05/03/2018 - Anika Therapeutics Joseph Darling Named CEO, Director; 15/03/2018 - Anika Non-Deal Roadshow Set By First Analysis for Mar. 22-23; 23/05/2018 - ANIKA THERAPEUTICS INC - PLANS TO UTILIZE EXISTING CASH ON HAND TO FUND ASR PROGRAM; 02/05/2018 - Anika Therapeutics 1Q Rev $21.3M

Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company has market cap of $727.05 million. The firm develops, makes, and commercializes therapeutic products based on its proprietary hyaluronic acid technology. It has a 25.86 P/E ratio. The Company’s orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment.

Oasis Petroleum Inc., an independent exploration and production company, focuses on the acquisition and development of unconventional oil and natural gas resources in the North Dakota and Montana regions of the Williston Basin. The company has market cap of $1.16 billion. As of December 31, 2016, the firm had 517,801 net leasehold acres in the Williston Basin; and approximately 305.1 million barrels of oil equivalent of estimated net proved reserves. It has a 5.31 P/E ratio. It also operates midstream services and a well services businesses.

Investors sentiment decreased to 1.04 in Q2 2019. Its down 0.14, from 1.18 in 2019Q1. It fall, as 42 investors sold Oasis Petroleum Inc. shares while 53 reduced holdings. 29 funds opened positions while 70 raised stakes. 262.38 million shares or 10.01% less from 291.58 million shares in 2019Q1 were reported. Los Angeles Capital Management & Equity Rech accumulated 0% or 21,048 shares. State Treasurer State Of Michigan reported 0% stake. Rafferty Asset Mngmt Ltd reported 0.08% stake. Commonwealth Of Pennsylvania Pub School Empls Retrmt reported 0% stake. Moreover, State Common Retirement Fund has 0% invested in Oasis Petroleum Inc. (NYSE:OAS) for 327,000 shares. Mutual Of America Cap Mngmt Lc holds 0.02% of its portfolio in Oasis Petroleum Inc. (NYSE:OAS) for 239,438 shares. Cubist Systematic Strategies Limited Liability Co owns 429,113 shares for 0.04% of their portfolio. Blackrock Inc, a New York-based fund reported 36.22M shares. Dupont Capital Mngmt Corp accumulated 41,700 shares or 0.01% of the stock. Weiss Multi invested in 0% or 20,197 shares. Proshare Advisors Ltd Com holds 65,385 shares or 0% of its portfolio. Susquehanna Gru Ltd Liability Partnership owns 329,961 shares. Caymus Cap L P, a Texas-based fund reported 2.01 million shares. Northwestern Mutual Wealth Management has 2,527 shares for 0% of their portfolio. Louisiana State Employees Retirement Systems holds 69,100 shares.

More notable recent Oasis Petroleum Inc. (NYSE:OAS) news were published by: which released: “Oasis Petroleum Parched But Could Come Back - Seeking Alpha” on September 21, 2019, also with their article: “Why Oil Stocks Are Up Big Today - The Motley Fool” published on August 28, 2019, published: “5 Cheap Energy Stocks to Buy Now -” on September 17, 2019. More interesting news about Oasis Petroleum Inc. (NYSE:OAS) were released by: and their article: “How Many Oasis Petroleum Inc. (NYSE:OAS) Shares Have Insiders Sold, In The Last Year? - Yahoo Finance” published on May 23, 2019 as well as‘s news article titled: “70 Biggest Movers From Yesterday - Benzinga” with publication date: September 17, 2019.

Since August 8, 2019, it had 1 buy, and 0 sales for $85,500 activity. The insider Hagale John E bought 30,000 shares worth $85,500.

Anika Therapeutics, Inc. (NASDAQ:ANIK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.